Department of Integrated Medical Care, Medical University of Białystok, Białystok, Poland,
Department of Integrated Medical Care, Medical University of Białystok, Białystok, Poland.
Dermatology. 2021;237(4):611-617. doi: 10.1159/000510654. Epub 2020 Aug 25.
Psoriasis is a systemic inflammatory disease capable of creating stigmatization in the form of social exclusion and decrement of psychological conditions.
The aim of the study was to determine the level of stigmatization in patients with plaque psoriasis.
The study included 166 patients with plaque psoriasis (55.6% women and 44.3% men) with Psoriasis Area and Severity Index scores ≤10. The age of the study patients ranged between 18 and 72 years (arithmetic mean = 37.4; median = 38; standard deviation [SD] = 11.0). The mean age at the diagnosis of psoriasis was 21.5 years (median = 20; SD = 9.1) and disease duration varied from 2 to 59 years (arithmetic mean = 15.8; median = 15; SD = 11.3). The study patients completed the Polish version of the 6-item Stigmatization Scale and the 33-item Feelings of Stigmatization Questionnaire and a survey developed by the authors of this study, containing questions about the participants' sociodemographic characteristics (sex, age, place of residence, marital status, education, employment status) and information about their disease (location of psoriatic lesions, time elapsed since the diagnosis of psoriasis).
The mean score for the 6-item Stigmatization Scale for the whole study group was 7.6 out of 18 points (median = 7; SD = 3.8; minimum = 0; maximum = 17). The average score for the 33-item Stigma Feelings Questionnaire in our series was 84.5 out of 165 points (median = 88; SD = 20.9; minimum = 30; maximum = 136). A statistically significant sex-related difference was observed in the 6-item Stigmatization Scale scores, with higher stigmatization levels found in men than in women (p = 0.0082). Moreover, significantly higher levels of stigmatization were observed in countryside dwellers (p = 0.0311) and unmarried persons (p = 0.0321). Patients with a longer history of the disease (≥15 years) scored significantly higher on the 6-item Stigmatization Scale (p = 0.0217) than those in whom psoriasis lasted less long, and presented with higher, at the threshold of statistical significance, scores for the 33-item Feelings of Stigmatization Questionnaire.
Stigmatization awareness should be promoted among physicians and psoriatic patients to improve psoriasis management.
银屑病是一种全身性炎症性疾病,可导致社会排斥和心理状况恶化等形式的污名化。
本研究旨在确定斑块状银屑病患者的污名化程度。
本研究纳入了 166 例斑块状银屑病患者(55.6%为女性,44.3%为男性),其银屑病面积和严重程度指数(PASI)评分≤10 分。研究患者的年龄在 18 至 72 岁之间(算术平均值=37.4;中位数=38;标准差[SD]=11.0)。银屑病的诊断年龄平均为 21.5 岁(中位数=20;SD=9.1),疾病持续时间为 2 至 59 年(算术平均值=15.8;中位数=15;SD=11.3)。研究患者完成了波兰语版的 6 项污名量表和 33 项污名感受问卷,以及由本研究作者开发的调查问卷,其中包含参与者的社会人口统计学特征(性别、年龄、居住地、婚姻状况、教育程度、就业状况)和有关其疾病的信息(银屑病病变的位置、银屑病诊断后时间)。
整个研究组的 6 项污名量表平均得分为 18 分中的 7.6 分(中位数=7;SD=3.8;最小值=0;最大值=17)。我们系列中的 33 项污名感受问卷的平均得分为 165 分中的 84.5 分(中位数=88;SD=20.9;最小值=30;最大值=136)。在 6 项污名量表评分中观察到了与性别相关的统计学显著差异,男性的污名化程度高于女性(p=0.0082)。此外,在农村居民(p=0.0311)和未婚者(p=0.0321)中观察到了更高的污名化程度。疾病史较长(≥15 年)的患者在 6 项污名量表上的得分显著高于疾病史较短的患者(p=0.0217),并且在 33 项污名感受问卷上的得分也更高,达到了统计学显著水平。
应向医生和银屑病患者宣传污名意识,以改善银屑病的管理。